Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Progression-free Survival and Safety at 3.5 Years of Follow-Up: Results from the Randomised Phase 3 PRIMA/ENGOT-OV26/GOG-3012 Trial of Niraparib Maintenance Treatment in Patients with Newly Diagnosed Ovarian Cancer

Antonio Gonzalez-Martin,Bhavana Pothuri,Ignace Vergote,Whitney Graybill,Domenica Lorusso,Colleen C. McCormick,Gilles Freyer,Floor Backes,Florian Heitz,Andres Redondo,Richard G. Moore,Christof Vulsteke,Roisin E. O'Cearbhaill,Izabela A. Malinowska,Luda Shtessel,Natalie Compton,Mansoor R. Mirza,Bradley J. Monk

Future Oncology（2024）

Cited 39|Views41
Key words
Advanced ovarian cancer,Niraparib,PARP inhibitor,Maintenance therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined